Mutual Fund Research

Nippon India Pharma Fund(G)

As on May-12-2021 change fund
289.70  up-0.65 (-0.22%)

fund objective

The primary investment objective of the Scheme is to generate consistent returns by investing in equity / equity related or fixed income securities of Pharma and other associated companies

riskometer

Investors understand that their principal will be at very high risk

5-Years History
financial year2016-20172017-20182018-20192019-20202020-2021
NAV in Rs (as on 31-Mar-2021)135.25133.66151.74143.39250.18
Net Assets(Rs Crores) (as on 31-Mar-2021) 1444.86 1875.94 2687.68 2189.84 4260.99
Scheme Returns(%)(Absolute)3.13-2.1113.53-5.8377.36
B'mark Returns(%)(Absolute)1.71-14.457.46-15.0279.08
Category Rank48/5651/629/7314/7532/75
Quarterly performance - Last 5 years (Absolute Ret. in %)
financial year Q1 Q2 Q3 Q4
2020-202131.5919.5012.24-1.15
2019-2020-6.50-1.118.38-5.70
2018-20196.9510.70-5.501.47
2017-2018-4.950.1912.03-7.37
2016-20172.177.77-7.220.87
Top 10 holdings
company (%)
Sun Pharmaceutical Industries...10.88 
Dr. Reddys Laboratories Ltd.9.93 
Aurobindo Pharma Ltd.9.78 
Cipla Ltd.9.08 
Lupin Ltd.8.89 
Divis Laboratories Ltd.8.87 
Cadila Healthcare Ltd.6.53 
Gland Pharma Ltd.6.50 
Fortis Healthcare Ltd.6.17 
Thyrocare Technologies Ltd.4.01 

Category

Sector Funds

Launch Date

05-Jun-04

Scheme Benchmark

S&P BSE HEALTH CARE - TRI

AUM ( in Cr.)

4,811.57

portfolio price to book value

5.54

investing style?

Large Growth

fund manager?

Sailesh Raj Bhan,Kinjal Desai

inception date (regular plan)

05-Jun-04

expense ratio (regular plan) %

1.94

Top 10 sectors
sectors (%)
Pharmaceuticals & Drugs80.86
Hospital & Healthcare Services15.40
Miscellaneous0.43

Growth Chart of the Scheme vis a vis benchmark (SIP value 10,000)

to go
  • 1M
  • 3M
  • 6M
  • 1Y
  • 3Y
  • 5Y
  • 10Y
  • maximum
performance comparision with similar schemes and benchmark
scheme name investment style inception date AUM in Cr. 1Y(%) 3Y(%) 5Y(%) 10Y(%) since inception
Nippon India Pharma Fund(G)Large-Growth 05-Jun-20044,811.5760.6527.8416.6218.0421.98
Tata India Pharma & Healthcare Fund-Reg(G)Large-Growth 28-Dec-2015492.0853.0724.4711.56NA9.77
UTI Healthcare Fund-Reg(G)Large-Growth 01-Aug-2005800.0259.6424.0512.4314.8419.12
SBI Healthcare Opp Fund-Reg(G)Large-Growth 14-Jul-19991,748.4061.5123.209.9917.5816.14
ICICI Pru Pharma Healthcare & Diagnostics (P.H.D) Fund-(G)Large-Growth 13-Jul-20182,549.0763.84NANANA27.06
DSP Healthcare Fund-Reg(G)Large-Growth 30-Nov-20181,236.1362.96NANANA35.02
Mirae Asset Healthcare Fund-Reg(G)Large-Growth 02-Jul-20181,458.9859.38NANANA29.92
Aditya Birla SL Pharma & Healthcare Fund-Reg(G)Large-Growth 10-Jul-2019508.9850.54NANANA38.32
IDBI Healthcare Fund-Reg(G)Large-Growth 28-Feb-201972.9145.67NANANA31.70
Attention InvestorsKYC
Contact Us

Mobile No : +91 99674 32226
Tel : 22702326
Email id : assist@reliabullwealth.com

OUR OFFICE

ReliaBull Financial Services Private Limited,
No 4-D, 4th Floor, Victoria Plaza,
SV Road, Above Kora Showroom,
Santacruz West,
Mumbai – 400054

Subscribe

For all the Latest Market News, Investment Ideas.

Follow us

AMFI Registration No:88227

A Reliabull Financial Services Venture

Designed & Developed by  Accord Fintech Pvt. Ltd.